Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.04B |
| 2 |
Verizon
VZ
|
+$459M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$448M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$738M |
| 2 |
iShares MBS ETF
MBB
|
+$390M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$216M |
| 4 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$202M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.49% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPMT
2551
Granite Point Mortgage Trust
GPMT
$70M
| $2.14M | ﹤0.01% |
399,603
+18,581
| +5% | +$121K |
|
|
ROCC
2552
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $2.14M | ﹤0.01% |
52,860
+501
| +1% | +$19.8K |
|
|
2553
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.5B
| $2.13M | ﹤0.01% |
36,467
-12,617,556
| -100% | -$738M |
|
|
MLNK
2554
DELISTED
MeridianLink
MLNK
| $2.13M | ﹤0.01% |
155,271
+2,211
| +1% | +$34.1K |
|
2555
United States Lime & Minerals
USLM
$3.25B
| $2.12M | ﹤0.01% |
75,465
+3,395
| +5% | +$87.6K |
|
2556
W&T Offshore
WTI
$512M
| $2.12M | ﹤0.01% |
380,348
+8,219
| +2% | +$56.6K |
|
2557
Organogenesis Holdings
ORGO
$306M
| $2.12M | ﹤0.01% |
788,061
+12,998
| +2% | +$37.9K |
|
2558
Ocugen
OCGN
$423M
| $2.11M | ﹤0.01% |
1,620,306
+61,826
| +4% | +$96.4K |
|
2559
RCI Hospitality Holdings
RICK
$195M
| $2.11M | ﹤0.01% |
22,601
+382
| +2% | +$31.8K |
|
2560
Pulmonx
LUNG
$75.6M
| $2.11M | ﹤0.01% |
249,836
-12,160
| -5% | -$116K |
|
2561
C4 Therapeutics
CCCC
$387M
| $2.1M | ﹤0.01% |
356,652
+4,527
| +1% | +$37.5K |
|
2562
FLEX LNG
FLNG
$1.67B
| $2.1M | ﹤0.01% |
64,197
+1,059
| +2% | +$35.4K |
|
2563
Microvast
MVST
$276M
| $2.1M | ﹤0.01% |
1,371,390
+53,870
| +4% | +$110K |
|
2564
Oscar Health
OSCR
$9.09B
| $2.08M | ﹤0.01% |
846,409
+29,212
| +4% | +$91.3K |
|
2565
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $2.07M | ﹤0.01% |
54,598
+35,927
| +192% | +$1.33M |
|
2566
Forestar Group
FOR
$1.45B
| $2.07M | ﹤0.01% |
134,237
+2,374
| +2% | +$31.4K |
|
|
CUTR
2567
DELISTED
Cutera, Inc.
CUTR
| $2.07M | ﹤0.01% |
46,715
+2,168
| +5% | +$98.9K |
|
|
LOGC
2568
DELISTED
ContextLogic
LOGC
| $2.05M | ﹤0.01% |
140,031
+11,234
| +9% | +$231K |
|
2569
Tarsus Pharmaceuticals
TARS
$2.67B
| $2.03M | ﹤0.01% |
138,551
+2,171
| +2% | +$35.9K |
|
2570
Expensify
EXFY
$177M
| $2.03M | ﹤0.01% |
229,756
+5,684
| +3% | +$63.7K |
|
2571
Heron Therapeutics
HRTX
$96.3M
| $2M | ﹤0.01% |
798,045
+57,039
| +8% | +$184K |
|
|
JOYY
2572
JOYY Inc
JOYY
$3.67B
| $1.99M | ﹤0.01% |
62,914
-214
| -0.3% | -$6.19K |
|
2573
Archer Aviation
ACHR
$3.72B
| $1.98M | ﹤0.01% |
1,060,596
+40,323
| +4% | +$99.5K |
|
2574
Cogent Biosciences
COGT
$6.68B
| $1.98M | ﹤0.01% |
171,305
+2,926
| +2% | +$36.3K |
|
2575
Vanguard Russell 2000 ETF
VTWO
$17.6B
| $1.98M | ﹤0.01% |
28,109
+23,043
| +455% | +$1.66M |
|
Similar funds
Charles Schwab's Q4 2022 Portfolio in Review
As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
- Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
- Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
- Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
- Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
- Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.
Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.